A detailed history of Cubist Systematic Strategies, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 6,600 shares of EXAS stock, worth $341,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,600
Holding current value
$341,484
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $12.4 Million - $15.9 Million
-209,806 Reduced 98.44%
3,333 $246,000
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $336,096 - $504,806
-5,097 Reduced 2.34%
213,139 $14.5 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $10.5 Million - $15.9 Million
167,459 Added 329.79%
218,236 $20.5 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $680,621 - $1.02 Million
14,423 Added 39.67%
50,777 $3.44 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $1.39 Million - $2.43 Million
-45,735 Reduced 55.71%
36,354 $1.8 Million
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $1.47 Million - $2.28 Million
-46,097 Reduced 35.96%
82,089 $2.67 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $243,109 - $520,422
6,827 Added 5.63%
128,186 $5.05 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $3.64 Million - $5.22 Million
63,208 Added 108.7%
121,359 $8.49 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $3.29 Million - $4.57 Million
45,347 Added 354.16%
58,151 $4.53 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $211,973 - $291,393
2,349 Added 22.47%
12,804 $1.22 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $979,215 - $1.46 Million
10,455 New
10,455 $1.3 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $8.34 Million - $11.1 Million
-71,526 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $4.86 Million - $6.94 Million
48,816 Added 214.95%
71,526 $9.48 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $162,611 - $227,482
-2,230 Reduced 8.94%
22,710 $2.32 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $1.39 Million - $2.31 Million
24,940 New
24,940 $2.17 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $448,091 - $1.23 Million
-11,823 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $128,682 - $165,269
-1,657 Reduced 12.29%
11,823 $1.09 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $7.19 Million - $9.75 Million
-79,591 Reduced 85.52%
13,480 $1.22 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $2.79 Million - $3.67 Million
31,121 Added 50.24%
93,071 $11 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $3.5 Million - $5.45 Million
56,457 Added 1027.8%
61,950 $5.37 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $56,264 - $82,990
-1,004 Reduced 15.45%
5,493 $347,000
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $6.43 Million - $10.7 Million
-133,221 Reduced 95.35%
6,497 $513,000
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $4.83 Million - $8.94 Million
127,757 Added 1068.11%
139,718 $8.35 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $467,208 - $674,999
11,733 Added 5146.05%
11,961 $482,000
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $188,191 - $244,944
-4,048 Reduced 94.67%
228 $12,000
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $158,425 - $201,485
4,276
4,276 $201,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.16B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.